Valuation: Strides Pharma Science Limited

Market Cap 101B 1.06B 946M 882M 800M 1.51B 1.52B 10.6B 4.15B 52.14B 3.97B 3.88B 168B P/E 2027 *
15.9x
P/E 2028 * 11.4x
Enterprise Value 101B 1.06B 946M 882M 800M 1.51B 1.52B 10.6B 4.15B 52.14B 3.97B 3.88B 168B EV / Sales 2027 *
1.74x
EV / Sales 2028 * 1.46x
Free-Float
68.12%
Yield 2027 *
0.28%
Yield 2028 * 0.28%
1 day+1.19%
1 week+0.94%
Current month-1.95%
1 month-4.90%
3 months+1.97%
6 months+9.42%
Current year+21.47%
1 week 1,067.3
Extreme 1067.3
1,109.6
1 month 1,067.3
Extreme 1067.3
1,260.1
Current year 769.6
Extreme 769.6
1,260.1
1 year 769.6
Extreme 769.6
1,260.1
3 years 467.4
Extreme 467.4
1,675.25
5 years 263.45
Extreme 263.45
1,675.25
10 years 263.45
Extreme 263.45
1,675.25
Manager TitleAgeSince
Chief Executive Officer - 31/05/2024
Director of Finance/CFO 42 31/05/2024
Chief Tech/Sci/R&D Officer - 20/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 17/05/2017
Director/Board Member 82 17/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+0.94% - - 1.03B
+0.39%+3.65%+44.60%+94.08% 1,051B
+1.01%+4.05%+37.86%+68.35% 630B
+1.49%+5.46%+21.70%+89.00% 489B
-0.09%+4.39%+69.96%+40.61% 359B
+0.61%+3.18%+24.10%+42.46% 344B
+0.72%+2.99%+14.79%+34.71% 272B
+0.23%+2.23%-5.49%+8.15% 246B
+0.66%+3.40%+42.50%+46.18% 224B
-0.59%+3.77%+26.96%+95.52% 187B
Average +0.49%+2.86%+30.78%+57.67% 422.63B
Weighted average by Cap. +0.52%+2.93%+34.71%+66.87%

Financials

2027 *2028 *
Net sales 58.23B 609M 545M 508M 461M 870M 875M 6.11B 2.39B 30.05B 2.29B 2.24B 96.7B 69.12B 723M 647M 603M 547M 1.03B 1.04B 7.25B 2.84B 35.67B 2.72B 2.66B 115B
Net income 6.28B 65.67M 58.79M 54.8M 49.71M 93.75M 94.34M 659M 258M 3.24B 247M 241M 10.42B 8.8B 92.04M 82.39M 76.81M 69.67M 131M 132M 923M 361M 4.54B 346M 338M 14.61B
Net Debt - -
Projected Income Statement - Annual - Strides Pharma Science Limited
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
12/10/26 ₹1,096.05 +1.19% 2,632
09/10/26 ₹1,083.20 -1.09% 9,598
08/10/26 ₹1,095.15 -0.45% 9,435
07/10/26 ₹1,100.05 +1.13% 4,179
06/10/26 ₹1,087.75 +0.17% 11,069
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Ratings Surperformance© - Strides Pharma Science Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,085.30INR
Average target price
1,338.67INR
Spread / Average Target
+23.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Strides Pharma Science Limited